Antovic A - Search Results

1

Comparison of two laboratory assays for the investigation of fibrin gel porosity.

Antovic A, Jörneskog G, Wallen NH. Antovic A, et al. Thromb Haemost. 2007 Dec;98(6):1386-8. doi: 10.1160/th07-06-0390. Thromb Haemost. 2007. PMID: 18064345 No abstract available.

2

Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.

Tehrani S, Jörneskog G, Ågren A, Lins PE, Wallén H, Antovic A. Tehrani S, et al. Among authors: antovic a. Thromb Haemost. 2015 Feb;113(2):312-8. doi: 10.1160/TH14-05-0404. Epub 2014 Oct 16. Thromb Haemost. 2015. PMID: 25318636

3

Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.

Antovic JP, Yngen M, Ostenson CG, Antovic A, Wallen HN, Jorneskög G, Blombäck M. Antovic JP, et al. Among authors: antovic a. Blood Coagul Fibrinolysis. 2003 Sep;14(6):551-6. doi: 10.1097/00001721-200309000-00006. Blood Coagul Fibrinolysis. 2003. PMID: 12960608

4

Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.

Tehrani S, Mobarrez F, Antovic A, Santesson P, Lins PE, Adamson U, Henriksson P, Wallén NH, Jörneskog G. Tehrani S, et al. Among authors: antovic a. Thromb Res. 2010 Sep;126(3):e225-31. doi: 10.1016/j.thromres.2010.05.023. Epub 2010 Jul 15. Thromb Res. 2010. PMID: 20637495 Clinical Trial.

5

Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.

Mobarrez F, He S, Bröijersen A, Wiklund B, Antovic A, Antovic J, Egberg N, Jörneskog G, Wallén H. Mobarrez F, et al. Among authors: antovic a, antovic j. Thromb Haemost. 2011 Aug;106(2):344-52. doi: 10.1160/TH10-12-0810. Epub 2011 May 26. Thromb Haemost. 2011. PMID: 21614411 Clinical Trial.

6

High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes.

Tehrani S, Antovic A, Mobarrez F, Mageed K, Lins PE, Adamson U, Wallén HN, Jörneskog G. Tehrani S, et al. Among authors: antovic a. Diabetes Care. 2012 Feb;35(2):404-8. doi: 10.2337/dc11-1302. Epub 2011 Dec 6. Diabetes Care. 2012. PMID: 22148098 Free PMC article. Clinical Trial.

7

The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment.

Mobarrez F, Abraham-Nordling M, Aguilera-Gatica K, Friberg I, Antovic A, Pisetsky DS, Jörneskog G, Wallen H. Mobarrez F, et al. Among authors: antovic a. Clin Endocrinol (Oxf). 2016 May;84(5):729-35. doi: 10.1111/cen.12872. Epub 2015 Sep 22. Clin Endocrinol (Oxf). 2016. PMID: 26252432

8

Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials.

He S, Cao H, Antovic A, Blombäck M. He S, et al. Among authors: antovic a. Blood Coagul Fibrinolysis. 2005 Jan;16(1):61-7. doi: 10.1097/00001721-200501000-00010. Blood Coagul Fibrinolysis. 2005. PMID: 15650548

9

Marked increase of fibrin gel permeability with very low dose ASA treatment.

Antovic A, Perneby C, Ekman GJ, Wallen HN, Hjemdahl P, Blombäck M, He S. Antovic A, et al. Thromb Res. 2005;116(6):509-17. doi: 10.1016/j.thromres.2005.02.007. Thromb Res. 2005. PMID: 16181986

10

Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand.

Antovic A, Mikovic D, Elezovic I, Zabczyk M, Hutenby K, Antovic JP. Antovic A, et al. Among authors: antovic jp. Thromb Haemost. 2014 Apr 1;111(4):656-61. doi: 10.1160/TH13-06-0479. Epub 2013 Nov 21. Thromb Haemost. 2014. PMID: 24258360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters